MR

Marsh & McLennan Companies, Inc.

MRSHFinancial ServicesNASDAQ

Insurance Brokers · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$26.98B
+10.3% YoY
Net Income
$4.16B
+2.5% YoY
EBITDA
$7.41B
+7.0% YoY
Free Cash Flow
$4.32B

Scan Results

Daily timeframe
10 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20CONFIRMED▼ RSI OverboughtRSI 89.0, above 70, stock may be overbought
Oct 19CONFIRMED▼ RSI OverboughtRSI 89.5, above 70, stock may be overbought
About Marsh & McLennan Companies, Inc.

Part of the financial services sector, Marsh & McLennan Companies, Inc. (MRSH) is listed under Insurance Brokers. The company carries a $93.90B market cap, placing it firmly in the large-cap category. The company operates through Risk and Insurance Services, and Consulting segments.

Where MRSH stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, MRSH finished 8.57% above its 150-day moving average ($173.62) and 7.89% above its 200-day moving average ($174.71). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is MRSH overbought or oversold?

At the October 20, 2026 close, MRSH's RSI(14) was 89.0, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$93.90B
P/E (TTM)23.62
Fwd P/E17.24
EPS$8.36
Beta0.58
52W Change+5.3%
Dividend Yield2.01%
ROE27.2%
Analysis

On the balance sheet, MRSH has $1.84B in cash with $22.33B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $4.32B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 27.2%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 7.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $20.72B (2022) to $26.98B (2025), reflecting a 30% increase over the period.

MRSH's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Marsh & McLennan Companies, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing MRSH.

Links
More Financial Services stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms